These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 25952770

  • 1. miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.
    Wang F, Lou JF, Cao Y, Shi XH, Wang P, Xu J, Xie EF, Xu T, Sun RH, Rao JY, Huang PW, Pan SY, Wang H.
    Exp Mol Med; 2015 May 08; 47(5):e162. PubMed ID: 25952770
    [Abstract] [Full Text] [Related]

  • 2. Serum microRNA 125b as a diagnostic or prognostic biomarker for advanced NSCLC patients receiving cisplatin-based chemotherapy.
    Cui EH, Li HJ, Hua F, Wang B, Mao W, Feng XR, Li JY, Wang X.
    Acta Pharmacol Sin; 2013 Feb 08; 34(2):309-13. PubMed ID: 22983388
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer.
    Li ZH, Zhang H, Yang ZG, Wen GQ, Cui YB, Shao GG.
    J Int Med Res; 2013 Oct 08; 41(5):1437-44. PubMed ID: 24065453
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G, Zhang J, Chen X.
    J Drug Target; 2016 Aug 08; 24(7):613-7. PubMed ID: 26581116
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9.
    Rao C, Miao X, Zhao G, Zhang C, Shen H, Dong C, Yang M.
    Biomed Pharmacother; 2019 Jun 08; 114():108662. PubMed ID: 30999114
    [Abstract] [Full Text] [Related]

  • 15. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H, Xie YZ, Xing R, Sun M, Chi F, Zeng YC.
    Cell Oncol (Dordr); 2017 Aug 08; 40(4):357-365. PubMed ID: 28567715
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.
    Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, Liu X.
    Cancer Genet; 2014 May 08; 207(5):214-20. PubMed ID: 24906642
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.